contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


duearity-americas-inc-has-signed-agreements-with-the-first-clinics-in-the-united-states

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Duearity

Duearity AB's subsidiary in the US, Duearity Americas Inc, has signed agreements with the first five clinics. The clinics intend to purchase Tinearity G1 for their tinnitus patients. A reasonable...

<div class="mfn-preamble"><p><strong>Duearity AB's subsidiary in the US, Duearity Americas Inc, has signed agreements with the first five clinics. The clinics intend to purchase Tinearity G1 for their tinnitus patients. A reasonable assessment is that approximately ten clinics in the US have entered into agreements with the company during the third quarter of 2023.</strong></p></div><div class="mfn-body"><p>Duearity Americas Inc has signed evaluation agreements with five clinics in the United States that intend to purchase Tinearity G1 for their tinnitus patients. The agreements mean that Duearity Americas Inc can carry out the first sales during the third quarter. Duearity received market approval on June 30 this year and sales activities started immediately after that. The assessment is that Duearity Americas Inc has entered into agreements with approximately ten clinics before the end of the third quarter.</p><p>- The interest among audiology clinics in the US has so far exceeded expectations and it is clear that Tinearity G1 fills a gap in the market. We will sell the device to clinics in a few selected states and aim to enter into distribution agreements in states that we do not intend to process ourselves. Another important channel is Veteran Affairs, which could become very profitable for the company, says David Johansson, Managing Director of Duearity Americas Inc.</p></div><div class="mfn-footer mfn-contacts mfn-365b0c3c64d7"><p><strong class="mfn-heading-1">For more information, please contact</strong></p><hr><p>Fredrik Westman, CEO<br>+46 738 - 145 215<br>fredrik.westman@duearity.com&nbsp;<br>www.duearity.com</p></div><div class="mfn-footer mfn-about mfn-57c6e976a4c7"><p><strong class="mfn-heading-1">About Duearity AB (publ)</strong></p><hr><p>Duearity is a medtech company that develops and produces solutions aiming to relieve tinnitus symptoms and make everyday life easier for those who suffer from tinnitus. The company will offer the products Tinearity and Tinearity-AI.</p><p>Tinearity G1 is CE marked, has 510(k) clearance and is sold in the EU and in the US.</p><p>Tinearity transmits white noise using Bone Conduction Technology to the inner ear in order to relieve symptoms. Tinearity AI will use artificial intelligence to help people anticipate the symptoms and relieve their discomfort.</p><p>The company is listed on Nasdaq First North. The company's headquarters are located in Malmö, Sweden.<br>Certified Adviser is Svensk Kapitalmarknadsgranskning AB (SKMG), <a rel="noopener" href="http://www.skmg.se/">www.skmg.se</a>.<br>www.duearity.com.<br></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/bd99f65d-f754-477d-92a6-0e54b29537ff/duearity-americas-inc-has-signed-agreements-with-the-first-clinics-in-the-united-states.pdf" class="mfn-generated mfn-primary">Duearity Americas Inc has signed agreements with the first clinics in the United States</a></p></div>

Duearity Americas Inc has signed agreements with the first clinics in the United States

Wall Streetin arvostustasoihin verrattuna Eurooppakin näyttää nyt houkuttelevalta

Federal Reserven korkopäätös: Kiire loppui tähän

Lääkekehityssijoittaminen: Arvonluonti yrityskaupoilla ja lisensointisopimuksilla

EKP:n korkopäätös: Keskuspankki ilman rajoitteita

Euroalueen ostopäälliköt: Onks sen jälkeen vielä mäki?

Pysy ajantasalla Inderesin uutiskirjeillä